Farallon Capital Management’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Farallon Capital Management’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-300,000	Closed	-$17.9M	–	142
2020 Q2	$17.9M	Sell	300,000 -84,674	-22%	-$5.23M	0.14%	92
2020 Q1	$22.8M	Sell	384,674 -15,326	-4%	-$893K	0.2%	65
2019 Q4	$21.9M	Buy	+400,000	New	+$14.9M	0.15%	81
2019 Q1	–	Sell	-350,000	Closed	-$9.59M	–	109
2018 Q4	$9.59M	Buy	350,000 +225,000	+180%	+$5.8M	0.07%	82
2018 Q3	$3.65M	Buy	+125,000	New	+$3.53M	0.02%	95

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Farallon Capital Management's PRNB Position: Q3 2020 in Review

Farallon Capital Management sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 300,000 shares — an estimated $17.9M sold.

Farallon Capital Management first reported a position in PRNB in Q3 2018 and held it in 5 quarters. The position peaked at $22.8M in Q1 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

Farallon Capital Management reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Farallon Capital Management sold 300,000 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $17.9M.
Farallon Capital Management first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 5 quarters.
Farallon Capital Management's Principia Biopharma Inc. Common Stock position peaked at $22.8M in Q1 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Farallon Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.